Omni Peptides

Thymosin Alpha-1 (TA1)

Dhs. 400.00 AED

Sale Sold out

VIAL

Freeze-dried powder in a sealed glass vial. Reconstitute with bacteriostatic water and administer via syringe. The most versatile and cost-effective research format.

RECONSTITUTION & SYRINGE REQUIRED

CARTRIDGE

Pre-filled and ready to administer. Slides into a reusable pen injector — no measuring or mixing required. Clean, discreet, and consistent across research protocols.

REQUIRES COMPATIBLE PEN INJECTOR

NASAL

Delivered via mucosal absorption — no needles required. A popular choice for research protocols where needle-free administration is preferred.

NEEDLE-FREE — SPRAY & GO

PEN

An all-in-one auto-injector with the cartridge pre-loaded. Dial, click, and administer. Optimal for high-frequency research protocols requiring precise, repeatable dosing.

DIAL, CLICK & INJECT — NO PREP

Vials are freeze-dried (lyophilised) powder — kept refrigerated unopened, they remain stable for up to 2 years.

Cartridges, nasal sprays, and pens arrive pre-filled as liquid, must be kept refrigerated at all times, and carry a Beyond Use Date — typically 4–8 weeks from receipt. Please refer to the BUD on the label.

Size 10mg

Immune support, antiviral/immune resilience

Thymosin Alpha-1 (also known as Tα1 or Thymalfasin) is a synthetic version of the naturally occurring 28-amino acid peptide originally isolated from thymic tissue. This research compound has been extensively studied for its potent immunomodulatory properties and its role in enhancing host defense mechanisms. Preliminary and advanced preclinical investigations demonstrate that Thymosin Alpha-1 may stimulate T-cell maturation and differentiation, restore immune function in immunocompromised states, enhance antiviral and antitumor immunity, and exert direct cytoprotective effects. Researchers utilize this peptide in laboratory and animal models to explore mechanisms of immune reconstitution, infectious disease resistance, and cancer immunotherapy. As a research-grade compound, Thymosin Alpha-1 is intended exclusively for in vitro and animal studies. Scientists value its well-documented stability, low immunogenicity, and ability to provide insights into thymic peptide-mediated immune regulation.

Molecular Formula

C₁₂₉H₂₁₅N₃₃O₅₅

Molecular Weight

3108.3 g/mol

Sequence

Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

Research Applications

Immune System Modulation and Restoration
Preclinical studies show that Thymosin Alpha-1 significantly enhances T-cell function, increases IL-2 receptor expression, and promotes differentiation of immature thymocytes into mature, functional T-cells, particularly in models of thymic involution, chemotherapy-induced immunosuppression, and aging.
Antiviral and Antimicrobial Defense
Extensive research demonstrates potent activity against a broad range of viral pathogens (including hepatitis B/C, influenza, HIV, and SARS-CoV models) through upregulation of interferon-α/β production, NK cell activity, and CD8+ cytotoxic T-cell responses.
Cancer Immunotherapy Support
Thymosin Alpha-1 augments antitumor immunity by enhancing dendritic cell maturation, promoting Th1 cytokine profiles, and increasing tumor infiltration by effector lymphocytes in various preclinical tumor models, often in combination with checkpoint inhibitors or chemotherapeutic agents.
Vaccine Adjuvant Potential
Studies indicate that Thymosin Alpha-1 improves both humoral and cellular immune responses to vaccines, increasing antibody titers and memory T-cell formation in immunocompromised or elderly subjects.
Anti-Inflammatory and Tissue Protection
It modulates excessive inflammatory responses by balancing pro- and anti-inflammatory cytokine production, reducing sepsis mortality in animal models, and protecting against oxidative stress and organ damage in critical illness scenarios.

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.